May oxidative stress contribute to autoimmune hepatitis pathogenesis, and can antioxidants be of value as adjuvant therapy for refractory patients?

Digestive Diseases and Sciences

Volumn 58, Issue 5, 2013, Pages 1440-1442

  Moreno Otero, Ricardo ^a,b  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; CORTICOSTEROID DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; REACTIVE OXYGEN METABOLITE; RIBAVIRIN;

ADJUVANT THERAPY; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE HEPATITIS; DISEASE COURSE; DNA DAMAGE; GENOTYPE; HEPATITIS C; HUMAN; LETTER; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER TRANSPLANTATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; SALVAGE THERAPY; VIRAL CLEARANCE;

HEPATITIS, AUTOIMMUNE; HUMANS; LIVER TRANSPLANTATION;

EID: 84878697497     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2622-0     Document Type: Letter

References (11)

1. Czaja AJ. Diagnosis, pathogenesis and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci. 2012;57:2248-2266.
2. Vidali M, Tripodi MF, Ivaldi A, et al. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol. 2008;48:399-406.
3. Feld JJ, Modi AA, El-Diwani R, et al. S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. Gastroenterology. 2011;140:830-839.
4. Tanaka H, Fujita N, Sugimoto R, et al. Hepatic oxidative DNA damage is associated with increased risk for hepatocellular carcinoma in chronic hepatitis C. Br J Cancer. 2008;98:580-586.
5. Sanz-Cameno P, Medina J, García-Buey L, et al. Enhanced intrahepatic inducible nitric oxide synthase expression and nitrotyrosine accumulation in primary biliary cirrhosis and autoimmune hepatitis. J Hepatol. 2002;37:723-729.
6. Majano PL, Medina J, Zubia I, et al. N-acetyl-cysteine modulates inducible nitric oxide synthase gene expression in human hepatocytes. J Hepatol. 2004;40:632-637.
7. Majano PL, García-Monzon C, García-Trevijano ER, et al. S-adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytes. J Hepatol. 2001;35:692-699.
8. Mato JM, Camara J, Fernandez de Paz J, et al. S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol. 1999;30:1081-1089.
9. Czaja AJ. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis. Curr Pharm Des. 2011;17:3120-3140.
10. Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25:6680-6684.
11. Desai D, Kaushal N, Gandhi UH, et al. Synthesis and evaluation of the anti-inflammatory properties of selenium-derivatives of celecoxib. Chem Biol Interact. 2010;188:446-456.